Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$943,069
+$940,963 QoQ
Shares Held
39,164
+52118.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,358
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $39,371,083 across 16 Drug Manufacturers - General names. PFE ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
42,985 | $10,816,745 | |
| 2 | JNJ |
Johnson & Johnson
|
39,578 | $10,051,624 | |
| 3 | LLY |
ELI LILLY & Co
|
4,333 | $5,197,130 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
64,156 | $3,696,668 | |
| 5 | AMGN |
Amgen Inc
|
9,053 | $3,278,272 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,458 | $2,628,853 | |
| 7 | PFE |
Pfizer Inc
This page
|
39,164 | $943,069 | |
| 8 | GSK |
GSK plc
|
16,758 | $878,454 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $943,069 | 39,164 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,106 | 75 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $827,999 | 33,253 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $919,420 | 36,084 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $922,235 | 38,046 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $992,846 | 39,181 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,038,516 | 39,145 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,185,064 | 40,949 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,068,416 | 38,185 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $990,869 | 35,707 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,185,802 | 41,188 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,803,727 | 84,526 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,092,160 | 84,301 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,730,784 | 66,931 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $3,210,595 | 62,658 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,219,773 | 73,578 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,035,015 | 57,887 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,459,178 | 47,502 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,522,793 | 42,723 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,218,025 | 51,570 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,821,527 | 46,515 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,314,170 | 36,273 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,518,118 | 41,242 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,496,477 | 40,776 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,306,922 | 39,967 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,301,779 | 39,883 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||